Neuroscience Letters 591 (2015) Christian Moritz, Francesco Berardi, Carmen Abate and Francesca Peri View Paper Post navigationPreviousPrevious post:Anavex to Present at Sigma-1 Receptors SymposiumNextNext post:Anavex Appoints Epilepsy and Clinical Trial Methodology Expert to Scientific Advisory BoardRelated PostsAnavex Life Sciences Provides Update on Clinical Program Development as Response to COVID-19March 31, 2020Anavex Life Sciences to Webcast 2020 Annual Meeting of ShareholdersMarch 23, 2020Anavex Life Sciences Reports Fiscal Year 2019 Financial Results And Provides Clinical Study UpdatesDecember 16, 2019Anavex Life Sciences to Announce Fiscal 2019 Year End Financial Results on Monday December 16, 2019December 10, 2019
Anavex Life Sciences Provides Update on Clinical Program Development as Response to COVID-19March 31, 2020
Anavex Life Sciences Reports Fiscal Year 2019 Financial Results And Provides Clinical Study UpdatesDecember 16, 2019
Anavex Life Sciences to Announce Fiscal 2019 Year End Financial Results on Monday December 16, 2019December 10, 2019
